Skip to main content
OpenTrials
Completed

NCT Number: NCT01955083

Analysis of Snore Sound Following Minimal Invasive Surgery in Sleep-disordered Breathing Patients

1. Background：The methods of anti-snore (treatment of snoring ) can be divided into conservative, invasive and minimal invasive treatment. IN brief, minimal invasive surgery involving radiofrequency and pillar implant demonstrates significantly improvement of snoring without major complication. Previous studies usually evaluated snoring through subjective measures such as visual analog scale visual analog scale. Rare reports analyzed snore sound instrumentally and no report demonstrates the correlation between subjective perception and objective assessment of snoring before and after surgical intervention. 2. Purposes：

1. Development of snore sound spectrum. 2. Exploration of the correlation between subjective perception and objective assessment of snoring. 3. Comparison of changes in snoring before and after minimal invasive surgery and between two kinds of MIS to have a understanding of surgical impact in subjective and objective measurement. 3. Method：We plan to enroll 30 subjects diagnosed by polysomnography as simple snoring or mild OSA with major complaint of snoring and favorable anatomic structure for minimal invasive surgery. All eligible subjects will be instructed the purpose, process and all related rights of this study and sign inform consent in outpatient clinic. Subjects start to complete Snore Outcome Survey (SOS, a validated questionnaire) and visual analog sure of snoring (VAS). Objective overnight snore sound recoding is arranged in sleep center. Subjects then receive minimal invasive surgery：radiofrequency or pillar implant of the soft palate by randomization. Both radiofrequency and pillar implant are common techniques in treating snoring and performed under local anesthesia as an outpatient procedure on sitting position. All subjects received repeated snore sound recording and completion of SOS and VAS three months after MIS. 4. Outcomes

1. Development of snore sound spectrum in sleep-disorder breathing patients. 2. Correlation of parameters between snore sound recording (loudness, frequency, count, regularity, etc ) and clinical parameters. 3. Correlation between objective (snore sound analysis) and subjective (SOS,VAS) assessment of snoring. 4. Comparison of changes in snoring (particular in objective assessment) after radiofrequency or pillar implant. 5. Comparison of changes in snoring between radiofrequency and pillar implant.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Primary Snoring Apnea Dyssomnias Nervous System Diseases Obstructive Sleep Apnea Pathological Conditions, Signs and Symptoms Respiration Disorders Respiratory Sounds Respiratory Tract Diseases Signs and Symptoms Signs and Symptoms, Respiratory Sleep Apnea Syndromes Sleep Apnea, Obstructive Sleep Disorders, Intrinsic Sleep Wake Disorders Snoring

Age range

20 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chang Gung Memorial Hospital

Kweishan, Taoyuan, 333, Taiwan

About this study

Recent publications have demonstrated reductions in snoring with several minimal invasive surgery (MIS) methods of the soft palate including radiofrequency (RF) surgery and pillar implant (PI). Despite modest effects in the treatment of obstructive sleep apnea, patients often wish to receive MIS for habitual snoring. However, the efficacy in reducing snoring has mainly been determined by self-reported questionnaires in the past. Further, the definition of surgical success in snoring treatment has not been universally defined. To date, changes in snoring sound characteristics following MIS have not been demonstrated.

Many cohort studies and a few randomized controlled trials or clinical controlled trials have compared MIS with a placebo, different energy generators, different material rigidity, or different operative techniques. RF of the soft palate produces volumetric tissue reduction and selective scar tissue5 to reduce obstruction and induce stiffness. However, the RF energy delivered to the soft palate can be inadequate and may result in residual or recurrent snoring. PI can decrease palatal flutter by increasing the rigidity of the soft palate through implant identity and tissue fibrosis. In addition, PI can be chronically retained in the muscle layer of the soft palate thereby producing a long-term anti-snoring effect. Nevertheless, whether PI provides a better efficacy in the treatment of snoring than RF surgery is still unknown.

The primary aim of the current study was to compare the anti-snoring effect between PI and RF by subjective assessments in a randomized controlled parallel trial. The secondary aim was to explore and compare the acoustic changes in snoring sounds after PI and RF.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • simple snoring or mild obstructive sleep apnea
  • major complaint of snoring
  • favorable anatomic structure for minimal invasive surgery.

Exclusion criteria

  • moderate or severe obstructive sleep apnea
  • pathological obesity
  • significant craniofacial anomaly
  • elderly
  • unfavorable anatomic structure for minimal invasive surgery.

Treatment and study plan

Pillar implant

Device

Subjects receive pillar implant of the soft palate under local anesthesia as an outpatient procedure on sitting position. Using the delivery tool of the pillar implant system, the mucosa of the soft palate close to the hard palate-soft palate junction (approximate 0.5 cm) was punctured in the midline. The needle was inserted to the uvular muscle and moved parallel to the curve of the soft palate towards the tip of the uvula. After reaching the insertion point, the implant was delivered steadily after which the needle was withdrawn. This process was repeated for the second and third implants in the bilateral para-midline with a 0.2 cm horizontal distance from the first implant.

Other names: Pillar implant (Medtronic Inc., USA)

Radiofrequency

Device

Subjects receive radiofrequency under local anesthesia as an outpatient procedure on sitting position. radiofrequency energy was delivered via a generator (Somnus® Model S2, Gyrus-ACMI Corporation, Maple Grove, MN, USA) with the power set to 10 watts and the maximal target temperature to 85°C. The needle electrode was inserted through the mucosa into the muscle layer at the entry points (approximately 1 cm below the hard palate-soft palate junction). The electrode was kept in place until 600 J had been delivered at the midline and 300 J at both para-midline sites (approximately 1 cm horizontal distance).

Other names: Somnus® Model S2 (Gyrus-ACMI Corporation, USA)

Primary outcomes

  1. Change in VAS Score After MIS

    Time frame: baseline and 3 months following surgery

    The mean change in subjective snoring severity (VAS) at 3 months after MIS was the primary outcome measurement.

Secondary outcomes

  1. Change in SOS Score After MIS

    Time frame: baseline and 3 months following surgery

    Change in SOS score at 3 months after radiofrequency or pillar implant were calculated.

  2. Percent Change in Total-SI After MIS

    Time frame: baseline and 3 months following surgery

    Percent change ([after value-before value]/[before value]*100) in Total-SI (event/hour) before and at 3 months after surgery was calculated.

  3. Percent Change in Total-Imax After MIS

    Time frame: baseline and 3 months following surgery

    Percent change ([after value-before value]/[before value]*100) in Total-Imax (dB) before and at 3 months after surgery was calculated.

  4. Percent Change in Total-Imean After MIS

    Time frame: baseline and 3 months following surgery

    Percent change ([after value-before value]/[before value]*100) in Total-Imean (dB) before and at 3 months after surgery was calculated.

  5. Percent Change in Total-Fpeak After MIS

    Time frame: baseline and 3 months following surgery

    Percent change ([after value-before value]/[before value]*100) in Total-Fpeak (Hz) before and at 3 months after surgery was calculated.

  6. Percent Change in Total-Fmean After MIS

    Time frame: baseline and 3 months following surgery

    Percent change ([after value-before value]/[before value]*100) in Total-Fmean (Hz) before and at 3 months after surgery was calculated.

  7. Percent Change in B1-SI After MIS

    Time frame: baseline and 3 months following surgery

    Percent change ([after value-before value]/[before value]*100) in B1-SI (event/hour) before and at 3 months after surgery was calculated.

  8. Percent Change in B1-Imax After MIS

    Time frame: baseline and 3 months following surgery

    Percent change ([after value-before value]/[before value]*100) in B1-Imax (dB) before and at 3 months after surgery was calculated.

  9. Percent Change in B1-Imean After MIS

    Time frame: baseline and 3 months following surgery

    Percent change ([after value-before value]/[before value]*100) in B1-Imean (dB) before and at 3 months after surgery was calculated.

  10. Percent Change in B1-Fpeak After MIS

    Time frame: baseline and 3 months following surgery

    Percent change ([after value-before value]/[before value]*100) in B1-Fpeak (Hz) before and at 3 months after surgery was calculated.

  11. Percent Change in B1-Fmean After MIS

    Time frame: baseline and 3 months following surgery

    Percent change ([after value-before value]/[before value]*100) in B1-Fmean (Hz) before and at 3 months after surgery was calculated.

Sponsors and collaborators

Lead sponsor

Chang Gung Memorial Hospital

Other

Collaborators

  • National Science and Technology Council, Taiwan

Registry information

Important dates

Study start
2010
Primary completion
2012
Study completion
2013
First posted
Oct 7, 2013
Registry last updated
Aug 18, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.